O ne of the major structural adaptations of the blood vessel in response to an elevation in blood pressure is the growth of vascular smooth muscle. Morphological studies have demonstrated that in the aorta this is due primarily to cellular hypertrophy. 1 -2 Interestingly, in the smaller mesenteric vessels this process appears to be principally due to cellular hyperplasia. 34 The factors that initiate and maintain this process have not been fully elucidated. One important mediator may be the vasoactive peptide angiotensin II (Ang II). Owens 5 reported that treatment of the spontaneously hypertensive rat with the angiotensin converting enzyme inhibitor captopril resulted in a reduction in aortic hypertrophy. This effect may be due, in part, to the blockade of Ang II production since captopril produced a greater reduction in thoracic aortic smooth muscle mass than the nonspecific vasodilator hydralazine, despite equal reduction in blood pressure. Further evidence for the participation of Ang II in the growth response has been provided by Geisterfer et al, 6 who demonstrated that Ang II, when added to aortic smooth muscle cells in culture, resulted in an increase in protein and DNA synthesis and cell size, without an increase in cell number.
One of the earliest responses of a resting cell after the addition of a growth promoting agent is induction of the expression of the proto-oncogene c-fos. This response has been demonstrated in a wide variety of cells.
-
12 Recently, it has been reported that the contractile agonist Ang II is capable of inducing the same response in quiescent cultured vascular smooth muscle cells. 13 - 15 However, it is not known at what level of control the induction by Ang II occurs. We report here that the addition of Ang II to quiescent cultures of rat aortic smooth muscle (RASM) cells results in a rapid stimulation of c-fos messenger RNA (mRNA) over a wide range of doses and is independent of protein synthesis. In fact, blockade of protein synthesis with cycloheximide resulted in a superinduction and stabilization of c-fos mRNA. We demonstrated further, by using a nuclear runoff transcription assay, that this rise in c-fos mRNA was due to an increase in transcription rate. These findings should provide an understanding of the mechanism of Ang II-induced smooth muscle hypertrophy.
Materials and Methods

Cell Culture
RASM cells (passage 8-18) were isolated and cultured according to the method of Gunther et al. 16 They were maintained in Dulbecco's Modified Eagle's Medium (DMEM) (GIBCO Labs., Grand Island, New York) with 10% fetal calf serum, penicillin (100 units/ml), streptomycin (100 /xg/ml), and 25 mM HEPES, pH 7.4. Cells were incubated at 37° C in a humidified atmosphere of 95% air-5% CO 2 . In preparation for experiments, the cells were made quiescent by placing them for 48 hours in a defined serum-free medium containing insulin (5xlO~7 M) (Sigma Chemical Co., St. Louis, Missouri), transferrin (5 fig/ml) ]Ang II (saralasin) were dissolved in 20 mM acetic acid at a concentration of 2 mg/ml. Cycloheximide was dissolved in distilled water at a concentration of 4 mg/ml. These compounds were added independently or together to the media of cultured RASM at zero time.
RNA Isolation
Cells were harvested at the indicated time points by directly adding 8 ml 4 M guanidium thiocyanate, 0.5% sodium AMauryl sarcosine, 25 mM sodium citrate, 2 M cesium chloride, and 0.1 M /3-mercaptoethanol to the flasks and gently scraping the cells. 18 The homogenate was sonicated, applied to 5 ml 5.7 M cesium chloride and 25 mM sodium acetate, pH 5.5, and centrifuged at 35,000 rpm for 16-18 hours at 20° C. The RNA was resuspended in 0.2 M sodium acetate and precipitated by ethanol. The RNA was resuspended in distilled water, quantitated by absorbance at 260 nM, and stored at -70° C for future use.
Northern Gel Analysis
RNA was lyophilized, denatured with 7.2% formaldehyde and 50% formamide (20 jul/25 fig RNA) , and run on 1.5% agarose gels containing 0.66 M formaldehyde in a buffer of 20 mM 3-[7V-morpholino] propanesulfonic acid (MOPS), 5 mM sodium acetate, and 1 mM EDTA, pH 7.0. The gels were electrophoresed at 100 V for 4 hours with constant circulation of the buffer. Gels were stained with ethidium bromide, photographed, and transferred to nylon filters (Gene Screen, New England Nuclear, Boston, Massachusetts) in 20xstandard saline citrate (SSC) (1 xSSC equals 0.15 M sodium chloride, and 0.15 M sodium citrate, pH 7.0).
Gels were baked in a vacuum oven at 80° C for 2 hours and prehybridized at 42° C for 3-4 hours in a buffer containing 5xDenhardts, 5xSSC, 50% formamide, 1% sodium dodecyl sulfate (SDS), 200 /xg/ml salmon sperm DNA, 100 fig/ml yeast transfer RNA, 10 /ig/ml poly A, and 10 /u,g/ml poly C. The blots were then hybridized in the same buffer at 42° C overnight with phosphorus-32-labeled DNA. After hybridization the blots were washed at room temperature in 2xSSC, 0.1% SDS and then with 0.2XSSC, 0.1% SDS at 65° C. Autoradiography was performed with Kodak XAR-5 film with intensifying screens (Du Pont, Wilmington, Delaware) at -70° C. The developed film was then scanned with an LKB microdensitometer (Paramus, New Jersey).
Plasmids
A plasmid containing the entire mouse c-fos gene fragment containing the entire coding region was used to label with 32 P (see below). In the nuclear runoff assays the plasmid bluescript S/K (Stratagene Inc., La Jolla, California), apUC19derivative, was used to detect any nonspecific hybridization.
Labeling of DNA
The c-fos fragment was labeled with 25 /xCi [ 32 P]deoxycytidine 5'-triphosphate (1,000-1,500 Ci/ mmol, New England Nuclear) using the random oligonucleotide method as described. 20 The phosphorus-32-labeled DNA was purified by Sephadex G-50 chromatography (Pharmacia LKB Biotechnology Inc., Piscataway, New Jersey).
Nuclear Runoff Transcription Assay
Nuclear runoff transcription assays were carried out by a modification of the method of Greenberg and Ziff . 7 Cells were washed with ice-cold phosphatebuffered saline (PBS) and harvested by scraping in cold PBS. Nuclei were isolated by lysis of cells with NP-40 (Sigma Chemical Co.) and centrifugation. Nuclei were incubated in the presence of 100 ju.Ci of [ 32 P]uridine triphosphate (UTP) (800 Ci/mmol, New England Nuclear) and 100 mM of UTP, adenosine triphosphate (ATP), guanosine triphosphate (GTP), and cytidine triphosphate (CTP) for 30 minutes at 30° C. The RNA was isolated and precipitated onto millipore type HA (0.45 /urn) filters with 10% trichloroacetic acid. The labeled RNA was eluted off the filters, and ethanol was precipitated. Equal numbers of counts (approximately 4xlO 6 ) were then hybridized to 10 pig of lineralized, denatured plasmid DNA that had been immobilized on nylon paper (gene screen, New England Nuclear) in 10 mM Ntris[hydroxymethyl]methyl-2-aminoethanesulfonic acid (TES), pH 7.4, 0.1% SDS, 10 mm EDTA, and 300 mM NaCl at 65° C for 36 hours. After hybridization the filters were washed with several changes of 2xSSC for 2 hours at 65° C, treated with ribonuclease A, washed in 2xSSC at 37° C for 1 hour, and exposed to Kodak XAR film at -70° C.
Results
Effect of Angiotensin II on Expression of c-fos Gene
There is no basal expression of c-fos in the quiescent RASM cells. When Ang II is added to these cells, there is a rapid and transient induction of the c-fos mRNA expression within 30 minutes. By 2 hours, c-fos mRNA can no longer be detected ( Figure 1 ). This response to Ang II is observed over a wide range of concentrations from 10~6-10~1 0 M and is dose dependent. The apparent half maximal response occurs at approximately 10~9 M (Figure 2) . It is also receptor-specific since it is completely blocked by an equimolar concentration of the competitive inhibitor, saralasin (Figure 3) .
Effect of Cycloheximide on Angiotensin-Induced c-fos Messenger RNA Expression
The angiotensin-induced c-fos mRNA expression is not dependent on protein synthesis as is seen in Figure 4 . Protein synthesis was blocked by the addition of cycloheximide (40 /xg/ml, final concentration) to cells at zero time. Cells were then treated with either Ang II (10~6 M, final concentration) or vehicle (20 mM acetic acid). Blockade of protein synthesis does not prevent the increase in c-fos mRNA, which is observed within 30 minutes. In fact there is evidence for superinduction as well as stabilization of the mRNA as it becomes detectable at the 2-hour time point. Cycloheximide by itself had no effect on c-fos expression at any time point (data not shown).
Nuclear Runoff Transcription
To assess the level of Ang II action, quiescent RASM cells were treated with Ang II (10~6 M, final concentration) or vehicle (20 mM acetic acid), and the nuclei were harvested at 30 minutes. This experiment has been done a total of five times, and a representative result is shown in Figure 5 . In the vehicle-treated cells there was no detectable c-fos transcription. In contrast, Ang II-treated cells exhib- ited a rapid increase in the c-fos transcription rate ( Figure 5 ). This increase was greatly diminished in 2 hours and was gone in 4 hours (data not shown).
An
The reaction is specific since no hybridization to the bluescript S/K plasmid is seen.
Discussion
In this study, we demonstrated that the contractile agonist Ang II induces the expression of the proto-oncogene c-fos in RASM cells within 30 minutes. This effect is transient since c-fos mRNA levels are back to nondetectable levels within 2 hours. This response is receptor specific and is linear over a wide range of Ang II concentrations. The apparent ED 50 is approximately 10~9 M. Since the dissociation constant (K d ) of the Ang II receptor in vascular smooth muscle is 2.8 nM, this response is well within the physiological range.
Our data elucidate the molecular mechanism by which Ang II induces c-fos gene expression. The observed increase in c-fos mRNA is not dependent on protein synthesis. Cycloheximide resulted in the apparent superinduction and stabilization of the c-fos mRNA, possibly due to the inhibition of the synthesis of ribonucleases that degrade the mRNA. This observation is consistent with the response of c-fos expression in other cell types to serum and other growth factors. 7 -9 Our data also demonstrated that angiotensin acts by increasing the c-fos RNA transcription rate, which is in agreement with the action of serum on cultured aortic smooth muscle 21 and 3T3 fibroblast cells. 7 The data suggest that the most likely scenario is that, in the absence of protein synthesis, Ang II activates preexisting nuclear proteins; the activated nuclear protein induces c-fos transcription. This proposed mechanism is similar to that described for serum on 3T3 fibroblast cells where at least three inducible nuclear binding proteins that bind to the 5'-regulatory region of the c-fos gene have been identified. 22 - 25 As in the case with Ang II, activation of these proteins by serum is not dependent on protein synthesis.
The significance of the angiotensin c-fos gene induction in vascular smooth muscle growth is not clear at the present time. In 3T3 cells, blockade of the rise in c-fos using antisense c-fos plasmids inhibits cell proliferation and growth. 2627 On the other hand, Berk et al 28 recently reported that pretreatment of smooth muscle cells with phorbol dibutyrate reduced the Ang II induction of c-fos mRNA by greater than 95% but did not affect the Ang II-induced increase in protein synthesis. This suggests that the increase in c-fos may not be related to the growth promoting effect of Ang II. However, this study failed to completely inhibit c-fos expression and could not exclude a permissive effect of a low level of c-fos. More work will be needed before this question can be answered.
If Ang II is responsible for the increase in smooth muscle growth in hypertension, a mechanism by which Ang II levels are elevated in chronic hypertension needs to be proposed. In most forms of chronic hypertension, plasma renin level and Ang II levels are normal or even low. 29 For example, the plasma renin level is normal in the spontaneously hypertensive rat, yet captopril reduces vascular hypertrophy. 5 Recently, all of the components of the renin-angiotensin system have been demonstrated in the vessel wall, 29 - 30 and in some experimental models of hypertension (e.g., the spontaneously hypertensive rat and the chronic two-kidney, one clip hypertensive model) there is evidence to suggest that this local tissue renin-angiotensin system is elevated in hypertension. 31 - 32 This raises the possibility that an autocrine or paracrine system exists, which may be activated in hypertension. The link between this system and vascular hypertrophy in hypertension is an important subject of future research. Finally, the significance of c-fos transcriptional activation by angiotensin in vascular smooth muscle growth deserves further investigation.
